LY3214996
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for LY3214996, covering 2024-08-07 to 2026-03-06. Get the full timeline:
Most recent: Clinical Trial Update: LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients [EARLY_Phase 1]